Singh N
Veterans Affairs Medical Center, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA 15240, USA.
Semin Gastrointest Dis. 1998 Jul;9(3):136-46.
Despite a declining incidence, infections remain a significant complication in liver transplant recipients. The spectrum of infections in transplant recipients, however, appears to be evolving. Infections caused by gram-positive bacteria (e.g., enterococci and staphylococci) have now surpassed in frequency those caused by gram-negative bacteria. There has been a decline in the incidence of Pneumocystis carinii and more recently cytomegalovirus infection in transplant recipients, largely as a result of effective prophylaxis. Opportunistic fungal infections (e.g., aspergillosis) remain problematic. New or previously unrecognized pathogens (e.g., human herpesvirus-6) may also be a significant cause of morbidity. Evaluation of infections in transplant recipients therefore requires understanding of not only classic opportunistic infections typically encountered in these patients, but also emerging trends in epidemiology, prophylaxis, and management.
尽管发病率在下降,但感染仍是肝移植受者的一个重要并发症。然而,移植受者的感染谱似乎正在演变。革兰氏阳性菌(如肠球菌和葡萄球菌)引起的感染现在在频率上已经超过了革兰氏阴性菌引起的感染。移植受者中卡氏肺孢子虫和最近巨细胞病毒感染的发病率有所下降,这主要是有效预防的结果。机会性真菌感染(如曲霉病)仍然是个问题。新的或以前未被认识的病原体(如人类疱疹病毒6型)也可能是发病的一个重要原因。因此,对移植受者感染的评估不仅需要了解这些患者通常遇到的典型机会性感染,还需要了解流行病学、预防和管理方面的新趋势。